Algorithm to precisely predict regional accumulation of pathological proteins as a diagnostic tool without PET protocols (Low-Cost/Risk-Free)
Compared to other products,
NeuroXT's NEXT-ATN shows superior amyloid positive prediction accuracy
and shows excellent performance in tau stage prediction.
Patient-specific suitability model via prediction of pathological protein accumulation (Patent Software)
We developed a neural connectome-based model of the amyloid/tau pathway that allows different treatment strategies to be used depending on the progress of Alzheimer's in each patient.
Multimodal model for quantifying Synaptic Integrity
in vivo to validate efficacy
of synapse targeted therapeutics (World’s first)
NEXT-S quantifies synaptic durability
to validate the efficacy of targeted treatments.
